The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
Open accessAbstract
c-Jun N-terminal kinases (JNKs) are a family of protein kinases that play a central role in stress signaling pathways implicated in gene expression, neuronal plasticity, regeneration, cell death, and regulation of cellular senescence. It has been shown that there is a JNK pathway activation after exposure to different stressing factors, including cytokines, growth factors, oxidative stress, unfolded protein response signals or Aβ peptides. Altogether, JNKs have become a focus of screening strategies searching for new therapeutic approaches to diabetes, cancer or liver diseases. In addition, activation of JNK has been identified as a key element responsible for the regulation of apoptosis signals and therefore, it is critical for pathological cell death associated with neurodegenerative diseases and, among them, with Alzheimer's disease (AD). In addition, in vitro and in vivo studies have reported alterations of JNK pathways potentially associated with pathogenesis and neuronal death in AD. JNK's, particularly JNK3, not only enhance Aβ production, moreover it plays a key role in the maturation and development of neurofibrillary tangles. This review aims to explain the rationale behind testing therapies based on inhibition of JNK signaling for AD in terms of current knowledge about the pathophysiology of the disease. Keeping in mind that JNK3 is specifically expressed in the brain and activated by stress-stimuli, it is possible to hypothesize that inhibition of JNK3 might be considered as a potential target for treating neurodegenerative mechanisms associated with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, P., Su, C., Li, R., Wang, H., Ren, Y., Sun, H., Yang, J., Sun, J., Shi, J., Tian, J., et al. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23322 · Cited by 65
RetractedSignal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“However, it is to note that SP600125 has shown a limited specificity toward JNK, as also inhibits not only MKK4 and MKK7, but also other protein kinases unrelated to JNK, such as SGK, p70 ribosomal protein S6 kinase (S6K1), AMPK, CDK2, CK1d, and DYRK1A (Bain et al., 2003).”
BackgroundAbsence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,238
Kuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 686
A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
Structure and Pathology of Tau Protein in Alzheimer Disease
Kolarova, M., García-Sierra, F., Bartos, A., Ricny, J., & Ripova, D. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/731526 · Cited by 468
Zhu, X., Raina, A. K., Rottkamp, C. A., Aliev, G., Perry, G., Boux, H., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00046.x · Cited by 421
Morishima, Y., Gotoh, Y., Zieg, J., Barrett, T., Takano, H., Flavell, R., Davis, R. J., Shirasaki, Y., & Greenberg, M. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07551.2001 · Cited by 404
Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
Chen, Y.-R., & Tan, T.-H. (1998) · Oncogene · doi:10.1038/sj.onc.1201941 · Cited by 392
c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
Bogoyevitch, M. A., Ngoei, K. R. W., Zhao, T. T., Yeap, Y. Y. C., & Ng, D. C. H. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.002 · Cited by 323
Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
The Parkinson Study Group PRECEPT Investigators (2007) · Neurology · doi:10.1212/01.wnl.0000277648.63931.c0 · Cited by 292
Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291
Salkovic-Petrisic, M., Knezovic, A., Hoyer, S., & Riederer, P. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-012-0877-9 · Cited by 272
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., & Barr, R. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.016 · Cited by 266
Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease
Guillozet-Bongaarts, A. L., Garcia-Sierra, F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Wang, T., Cahill, M. E., Bigio, E. H., Berry, R. W., & Binder, L. I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.019 · Cited by 256
Giuliani, D., Ottani, A., Zaffe, D., Galantucci, M., Strinati, F., Lodi, R., & Guarini, S. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.05.006 · Cited by 254
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
Tang, S.-C., Lathia, J. D., Selvaraj, P. K., Jo, D.-G., Mughal, M. R., Cheng, A., Siler, D. A., Markesbery, W. R., Arumugam, T. V., & Mattson, M. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.014 · Cited by 232
Yao, M., Nguyen, T.-V. V., & Pike, C. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4736-04.2005 · Cited by 231
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Yoon, S. O., Park, D. J., Ryu, J. C., Ozer, H. G., Tep, C., Shin, Y. J., Lim, T. H., Pastorino, L., Kunwar, A. J., Walton, J. C., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.024 · Cited by 230
beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
Troy, C. M., Rabacchi, S. A., Xu, Z., Maroney, A. C., Connors, T. J., Shelanski, M. L., & Greene, L. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00218.x · Cited by 223
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
Killick, R., Ribe, E. M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., Dobson, R., Nolan, P. M., Lourdusamy, A., Furney, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.163 · Cited by 222
Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms
Grimm, M. O. W., Kuchenbecker, J., Grösgen, S., Burg, V. K., Hundsdörfer, B., Rothhaar, T. L., Friess, P., de Wilde, M. C., Broersen, L. M., Penke, B., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182329 · Cited by 220
Specific pathophysiological functions of JNK isoforms in the brain
Brecht, S., Kirchhof, R., Chromik, A., Willesen, M., Nicolaus, T., Raivich, G., Wessig, J., Waetzig, V., Goetz, M., Claussen, M., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03857.x · Cited by 219
Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity
Barr, R. K., Kendrick, T. S., & Bogoyevitch, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107565200 · Cited by 211
MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE
Wang, L. H., & Johnson, E. M. (2008) · Neurology · doi:10.1212/01.wnl.0000324506.93877.5e · Cited by 204
JNK pathway: diseases and therapeutic potential
CUI, J., ZHANG, M., ZHANG, Y.-Q., & XU, Z.-H. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00579.x · Cited by 201
Phosphorylation of microtubule‐associated protein tau by isoforms of c‐Jun N‐terminal kinase (JNK)
Yoshida, H., Hastie, C. J., McLauchlan, H., Cohen, P., & Goedert, M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02479.x · Cited by 183
Marques, C. A., Keil, U., Bonert, A., Steiner, B., Haass, C., Müller, W. E., & Eckert, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212265200 · Cited by 175
Guillozet‐Bongaarts, A. L., Cahill, M. E., Cryns, V. L., Reynolds, M. R., Berry, R. W., & Binder, L. I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03784.x · Cited by 170
JNK activation is associated with intracellular β-amyloid accumulation
Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C. F., Ono, S., & Okazawa, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00245-x · Cited by 166
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
Colombo, A. V., Bastone, A., Ploia, C., Sclip, A., Salmona, M., Forloni, G., & Borsello, T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.014 · Cited by 162
Bozyczko‐Coyne, D., O’Kane, T. M., Wu, Z.-L., Dobrzański, P., Murthy, S., Vaught, J. L., & Scott, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00294.x · Cited by 153
Physiological Roles of SAPK/JNK Signaling Pathway
Nishina, H., Wada, T., & Katada, T. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh117 · Cited by 147
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 144
Waetzig, V., Zhao, Y., & Herdegen, T. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.002 · Cited by 131
Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro
Sze, C.-I., Su, M., Pugazhenthi, S., Jambal, P., Hsu, L.-J., Heath, J., Schultz, L., & Chang, N.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401399200 · Cited by 130
Inhibitors of c-Jun N-terminal kinases—JuNK no more?
Bogoyevitch, M. A., & Arthur, P. G. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.013 · Cited by 130
Mudher, A. K., Chapman, S. C., Richardson, J. C., Asuni, A. A., Gibb, G., Pollard, C. C., Killick, R., Iqbal, T. A., Raymond, F. L., Varndell, I. M., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-04987.2001 · Cited by 127
Bevilaqua, L. R., Kerr, D. S., Medina, J. H., Izquierdo, I., & Cammarota, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02524.x · Cited by 126
Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
Maiti, P., Manna, J., Veleri, S., & Frautschy, S. A. (2014) · BioMed Research International · doi:10.1155/2014/495091 · Cited by 122
Uitdehaag, J. C. M., Verkaar, F., Alwan, H. A. J., de Man, J., Buijsman, R. C., & Zaman, G. J. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01859.x · Cited by 113
Zhou, Q., Wang, M., Du, Y., Zhang, W., Bai, M., Zhang, Z., Li, Z., & Miao, J. (2015) · Annals of Neurology · doi:10.1002/ana.24361 · Cited by 112
Yu, S., Zheng, W., Xin, N., Chi, Z., Wang, N.-Q., Nie, Y.-X., Feng, W., & Wang, Z. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0908 · Cited by 109
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
Sclip, A., Tozzi, A., Abaza, A., Cardinetti, D., Colombo, I., Calabresi, P., Salmona, M., Welker, E., & Borsello, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.559 · Cited by 108
The JNK/c-Jun cascade and Alzheimer's disease
Okazawa, H., & Estus, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700209 · Cited by 104
Inhibitors of c-Jun N-Terminal Kinases: An Update
Koch, P., Gehringer, M., & Laufer, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501212r · Cited by 103
Holzberg, D., Knight, C. G., Dittrich‐Breiholz, O., Schneider, H., Dörrie, A., Hoffmann, E., Resch, K., & Kracht, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304058200 · Cited by 102
Saporito, M. S., Hudkins, R. L., & Maroney, A. C. (2002) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70081-x · Cited by 98
Gourmaud, S., Paquet, C., Dumurgier, J., Pace, C., Bouras, C., Gray, F., Laplanche, J., MEURS, E. F., Mouton‐Liger, F., & Hugon, J. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140062 · Cited by 98
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
Volk, A. G., Li, J., Xin, J., You, D., Zhang, J., Liu, X., Xiao, Y., Breslin, P., Li, Z., Wei, W., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130990 · Cited by 96
Tran, H., Sanchez, L., & Brody, D. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182456aed · Cited by 93
Xiong, H., Chen, Z., Wang, J., Song, J., Zhao, G., Shen, H., & Deng, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130584 · Cited by 90
Goodfellow, V. S., Loweth, C. J., Ravula, S. B., Wiemann, T., Nguyen, T. T., Xu, Y., Todd, D. E., Sheppard, D. W., Pollack, S. J., Polesskaya, O., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401094t · Cited by 89
JNK3 as a Therapeutic Target for Neurodegenerative Diseases
Antoniou, X., Falconi, M., Marino, D. D., & Borsello, T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-091567 · Cited by 89
c-Jun N-terminal Kinase Regulates Soluble Aβ Oligomers and Cognitive Impairment in AD Mouse Model
Sclip, A., Antoniou, X., Colombo, A. V., Camici, G. G., Pozzi, L., Cardinetti, D., Feligioni, M., Veglianese, P., Bahlmann, F. H., Cervo, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297515 · Cited by 87
Secreted β-amyloid precursor protein activates microglia via JNK and p38-MAPK
Bodles, A. M., & Barger, S. W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.022 · Cited by 84
The role of scaffold proteins in JNK signalling
Engström, W., Ward, A., & Moorwood, K. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00654.x · Cited by 83
Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
Siddiqui, M. A., & Reddy, P. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9003279 · Cited by 77
Hashimoto, Y., Niikura, T., Chiba, T., Tsukamoto, E., Kadowaki, H., Nishitoh, H., Yamagishi, Y., Ishizaka, M., Yamada, M., Nawa, M., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051383 · Cited by 77
Chuang, J., Huang, Y., Yen, W.-L., Chiang, I., Tsai, M., & Tang, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010545 · Cited by 73
Ramin, M., Azizi, P., Motamedi, F., Haghparast, A., & Khodagholi, F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.017 · Cited by 71
Feld, M., Krawczyk, M., Fustiñana, M. S., Blake, M., Baratti, C., Romano, A., & Boccia, M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131076 · Cited by 70
Marker, D. F., Tremblay, M., Puccini, J. M., Barbieri, J., Marker, M. A. G., Loweth, C. J., Muly, E. C., Lu, S., Goodfellow, V. S., Dewhurst, S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0598-13.2013 · Cited by 69
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Haas, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110986 · Cited by 68
The JNK pathway amplifies and drives subcellular changes in tau phosphorylation
Vogel, J. W., Anand, V. S., Ludwig, B., Nawoschik, S. P., Dunlop, J., & Braithwaite, S. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.021 · Cited by 68
Hong, Y. K., Lee, S., Park, S. H., Lee, J. H., Han, S. Y., Kim, S., Kim, Y., Jeon, S., Koo, B., & Cho, K. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.122 · Cited by 66
Sahara, N., Murayama, M., Lee, B., Park, J., Lagalwar, S., Binder, L. I., & Takashima, A. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06258.x · Cited by 63
Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease
Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229236.98124.d8 · Cited by 63
Goodman, Y., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)90223-2 · Cited by 60
Costello, D. A., & Herron, C. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.016 · Cited by 58
Okada, M., Satō, A., Shibuya, K., WATANABE, E., Seino, S., Suzuki, S., Seino, M., Narita, Y., Shibui, S., Kayama, T., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2209 · Cited by 57
c-JunN-terminal kinase inhibitors: a patent review (2010 – 2014)
Gehringer, M., Muth, F., Koch, P., & Laufer, S. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1039984 · Cited by 56
Carola Otth, L., Mendoza‐Naranjo, A., Mujica, L., Zambrano, Á., Concha, I. I., & Maccioni, R. B. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00023 · Cited by 56
Dietary lipids and their oxidized products in Alzheimer's disease
Corsinovi, L., Biasi, F., Poli, G., Leonarduzzi, G., & Isaia, G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100208 · Cited by 56
The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD
Parkinson Study Group (2004) · Neurology · doi:10.1212/01.wnl.0000103882.56507.20 · Cited by 54
Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains
Pearson, A. G., Byrne, U. T. E., MacGibbon, G. A., Faull, R. L. M., & Dragunow, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.031 · Cited by 53
JNK pathway may be involved in isoflurane-induced apoptosis in the hippocampi of neonatal rats
Li, Y., Wang, F., Liu, C., Zeng, M.-T., Han, X., Luo, T., Jiang, W., Xu, J., & Wang, H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.008 · Cited by 52
Martišová, E., Aisa, B., Gereñu, G., & Ramírez, M. J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040007 · Cited by 52
Impaired long‐term potentiation in c‐Jun N‐terminal kinase 2‐deficient mice
Chen, J., Lu, D., Chia, C., Ruan, D., Sabapathy, K., & Xiao, Z. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03037.x · Cited by 51
Solas, M., Aisa, B., Tordera, R. M., Mugueta, C., & Ramírez, M. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.013 · Cited by 51
Self-citationDhikav, V., & Anand, K. S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.038 · Cited by 50
Eminel, S., Roemer, L., Waetzig, V., & Herdegen, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05101.x · Cited by 50
Xu, Y., Hou, X., Liu, Y. U., & Zong, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21909 · Cited by 44
Use of cell-permeable peptides to prevent neuronal degeneration
Borsello, T., & Bonny, C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.03.008 · Cited by 44
Cao, M., Liu, F., Ji, F., Liang, J., Liu, L., Wu, Q., & Wang, T. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.040 · Cited by 41
Cho, E. S., Jang, Y. J., Kang, N. J., Hwang, M. K., Kim, Y. T., Lee, K. W., & Lee, H. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.010 · Cited by 39
Solas, M., Gereñu, G., Gil-Bea, F. J., & Ramírez, M. J. (2012) · Journal of Neuroendocrinology · doi:10.1111/jne.12006 · Cited by 37
Self-citationGanguly, A., Oo, T. F., Rzhetskaya, M., Pratt, R., Yarygina, O., Momoi, T., Kholodilov, N. G., & Burke, R. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02176.x · Cited by 36
Arthur, P. G., Matich, G. P., Pang, W. W., Yu, D., & Bogoyevitch, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04618.x · Cited by 34
Rahman, M. M., Zhang, Z., Mody, A. A., Su, D., & Das, H. K. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.066 · Cited by 30
Ma, G., Chen, S., Wang, X., Ba, M., Yang, H., & Lü, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20515 · Cited by 30
Bamji‐Mirza, M., Callaghan, D., Najem, D., Shen, S., Hasim, M. S., Yang, Z., & Zhang, W. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131949 · Cited by 26
Kim, J.-H., Chae, M., Choi, A., Kim, H. S., & Yoon, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.026 · Cited by 26
Suwanna, N., Thangnipon, W., & Soi‐ampornkul, R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.029 · Cited by 26
Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo
Pocivavsek, A., & Rebeck, G. W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.048 · Cited by 24
Das, H. K., Tchedre, K. T., & Mueller, B. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07794.x · Cited by 22
Funakoshi‐Tago, M., Nagata, T., Tago, K., Tsukada, M., Tanaka, K., Nakamura, S., Mashino, T., & Kasahara, T. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.06.014 · Cited by 20
Ma, Chen, Wang, Ba, Yang, & Lü (2006) · 中国生物学文摘 · Cited by 19
Induction of GADD34 Regulates the Neurotoxicity of Amyloid β
Xu, N., Xiao, Z.-J., Zou, T., & Huang, Z. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514545616 · Cited by 17
Chae, S. S., Yoo, C. B., Jo, C., Yun, S., Jo, S. A., & Koh, Y. H. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22356 · Cited by 15
Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer’s disease
Feng, H., Fan, H., Dang, H.-Z., Chen, X., Ren, Y., Yang, J.-D., & Wang, P. (2014) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20141936 · Cited by 14
Cited by
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2025) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 410
A Review on Caspases: Key Regulators of Biological Activities and Apoptosis
Sahoo, G., Samal, D., Khandayataray, P., & Murthy, M. K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03433-5 · Cited by 387
Tau-targeting therapies for Alzheimer disease: Current status and future directions
Congdon, E. E., Ji, C., Tetlow, A. M., Jiang, Y., & Sigurdsson, E. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00883-2 · Cited by 371
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
Metadata
- Authors
- Yarza, R., Vela, S., Solas, M., & Ramirez, M. J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2016-01-12
- Volume
- 6
- Pages
- 321-321
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2257129080
- Cited by
- 410
- References
- 109
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.